{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:17:31Z","timestamp":1750220251795,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":38,"publisher":"ACM","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12,22]]},"DOI":"10.1145\/3508546.3508584","type":"proceedings-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T11:53:44Z","timestamp":1645790024000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The m6A RNA methylation regulators related transcriptome for identification of pancreatic cancer subtypes and prognostic markers"],"prefix":"10.1145","author":[{"given":"Zhengshu","family":"Lu","sequence":"first","affiliation":[{"name":"Laboratory of Media Design and Software Technology, Jiangnan University, China"}]},{"given":"Yanrui","family":"Ding","sequence":"additional","affiliation":[{"name":"School of science, Jiangnan University, China"}]}],"member":"320","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"volume-title":"Cancers","author":"Hofmann Thomas G","key":"e_1_3_2_1_1_1","unstructured":"Frappart. Pierre-Olivier, Thomas G Hofmann . Pancreatic Ductal Adenocarcinoma (PDAC) Organoids : The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine .\u201d Cancers vol. 2020;10: 2750 . Frappart. Pierre-Olivier,Thomas G Hofmann.Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine.\u201d Cancers vol. 2020;10:2750."},{"key":"e_1_3_2_1_2_1","volume-title":"Cancer statistics","author":"Siegel R.L.","year":"2020","unstructured":"Siegel R.L. , Miller K.D., Jemal A. Cancer statistics , 2020 . CA Cancer J. Clin . 2020;70:7\u201330. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7\u201330."},{"key":"e_1_3_2_1_3_1","doi-asserted-by":"crossref","unstructured":"Bilimoria K.Y. Bentrem D.J. Ko C.Y. Stewart A.K. Winchester D.P. Talamonti M.S. National failure to operate on early stage pancreatic cancer. Ann. Surg. 2007;246:173\u2013180.  Bilimoria K.Y. Bentrem D.J. Ko C.Y. Stewart A.K. Winchester D.P. Talamonti M.S. National failure to operate on early stage pancreatic cancer. Ann. Surg. 2007;246:173\u2013180.","DOI":"10.1097\/SLA.0b013e3180691579"},{"key":"e_1_3_2_1_4_1","doi-asserted-by":"crossref","unstructured":"Buanes T.A. Role of surgery in pancreatic cancer. World J. Gastroenterol. 2017;23:3765\u20133770.  Buanes T.A. Role of surgery in pancreatic cancer. World J. Gastroenterol. 2017;23:3765\u20133770.","DOI":"10.3748\/wjg.v23.i21.3765"},{"key":"e_1_3_2_1_5_1","doi-asserted-by":"crossref","unstructured":"Von Hoff D.D. Ervin T. Arena F.P. Chiorean E.G. Infante J. Moore M. Seay T. Tjulandin S.A. Ma W.W. Saleh M.N. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 2013;369:1691\u20131703.  Von Hoff D.D. Ervin T. Arena F.P. Chiorean E.G. Infante J. Moore M. Seay T. Tjulandin S.A. Ma W.W. Saleh M.N. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 2013;369:1691\u20131703.","DOI":"10.1056\/NEJMoa1304369"},{"key":"e_1_3_2_1_6_1","doi-asserted-by":"crossref","unstructured":"Goldstein D. El-Maraghi R.H. Hammel P. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Long-term survival from a phase III trial. J. Natl. Cancer Inst. 2015;107  Goldstein D. El-Maraghi R.H. Hammel P. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Long-term survival from a phase III trial. J. Natl. Cancer Inst. 2015;107","DOI":"10.1093\/jnci\/dju413"},{"key":"e_1_3_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(83)90508-1"},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"crossref","unstructured":"Liu Zhicheng Li Shanshan Huang Shan Wang Tao Liu Zhicheng. N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling. Frontiers in Oncology. 2021;11: 2998.  Liu Zhicheng Li Shanshan Huang Shan Wang Tao Liu Zhicheng. N6-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling. Frontiers in Oncology. 2021;11: 2998.","DOI":"10.3389\/fonc.2021.704543"},{"key":"e_1_3_2_1_9_1","doi-asserted-by":"crossref","unstructured":"Sun T Wu R Ming L. The Role of m6A RNA Methylation in Cancer. BioMed Pharmacother (2019) 112: 108613.  Sun T Wu R Ming L. The Role of m6A RNA Methylation in Cancer. BioMed Pharmacother (2019) 112:108613.","DOI":"10.1016\/j.biopha.2019.108613"},{"key":"e_1_3_2_1_10_1","doi-asserted-by":"crossref","unstructured":"Ping X Sun B Wang L Xiao W Yang X Wang W Mammalian WTAP is a Regulatory Subunit of the RNA N6-Methyladenosine Methyltransferase. Cell Res (2014) 24(2): 177\u201389.  Ping X Sun B Wang L Xiao W Yang X Wang W Mammalian WTAP is a Regulatory Subunit of the RNA N6-Methyladenosine Methyltransferase. Cell Res (2014) 24(2):177\u201389.","DOI":"10.1038\/cr.2014.3"},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"crossref","unstructured":"Yang Y Hsu PJ Chen Y Yang Y. Dynamic Transcriptomic m6A Decoration: Writers Erasers Readers and Functions in RNA Metabolism. Cell Res (2018) 28(6): 616\u201324.  Yang Y Hsu PJ Chen Y Yang Y. Dynamic Transcriptomic m6A Decoration: Writers Erasers Readers and Functions in RNA Metabolism. Cell Res (2018) 28(6):616\u201324.","DOI":"10.1038\/s41422-018-0040-8"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Meyer KD Jaffrey SR. Rethinking m6A Readers Writers and Erasers. Annu Rev Cell Dev Biol (2017) 33: 319\u201342.  Meyer KD Jaffrey SR. Rethinking m6A Readers Writers and Erasers. Annu Rev Cell Dev Biol (2017) 33:319\u201342.","DOI":"10.1146\/annurev-cellbio-100616-060758"},{"key":"e_1_3_2_1_13_1","volume-title":"Cell","author":"Roundtree Ian A.","year":"2017","unstructured":"Ian A. Roundtree , Molly E. Evans , Tao Pan , Chuan He . Dynamic RNA Modifications in Gene Expression Regulation , Cell , 2017 ; 169:1187-1200 Ian A. Roundtree, Molly E. Evans, Tao Pan, Chuan He. Dynamic RNA Modifications in Gene Expression Regulation, Cell, 2017; 169:1187-1200"},{"key":"e_1_3_2_1_14_1","volume-title":"RNA Biology,2021","author":"Ge Yiling","year":"1974","unstructured":"Yiling Ge , Tong Liu , Chuntao Wang , Yanqiu Zhang , Siyi Xu , Yiyi Ren , Yanlu Feng , Lihong Yin , Yuepu Pu & Geyu Liang . N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer , RNA Biology,2021 ; 1974 749:1-11 Yiling Ge, Tong Liu, Chuntao Wang, Yanqiu Zhang, Siyi Xu, Yiyi Ren, Yanlu Feng, Lihong Yin, Yuepu Pu & Geyu Liang. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer, RNA Biology,2021; 1974749:1-11"},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"crossref","unstructured":"He L Li H Wu A Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019 Dec 4;18(1):176.  He L Li H Wu A Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019 Dec 4;18(1):176.","DOI":"10.1186\/s12943-019-1109-9"},{"volume-title":"Shen, Lisha, Yu, Hao. N6-methyladenosine modification underlies messenger RNA metabolism and plant development. View Web of Science ResearcherID and ORCID. 2021","year":"2047","key":"e_1_3_2_1_16_1","unstructured":"Shao, Yanlin, Wong , Chui Eng , Shen, Lisha, Yu, Hao. N6-methyladenosine modification underlies messenger RNA metabolism and plant development. View Web of Science ResearcherID and ORCID. 2021 ; 63:10 2047 Shao, Yanlin, Wong, Chui Eng, Shen, Lisha, Yu, Hao. N6-methyladenosine modification underlies messenger RNA metabolism and plant development. View Web of Science ResearcherID and ORCID. 2021; 63:102047"},{"key":"e_1_3_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2020.03.005"},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.003"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Lan Q Liu PY Haase J Bell JL Huttelmaier S Liu T. The critical role of RNA m(6) a methylation in Cancer. Cancer Res. 2019;79(7):1285\u201392.  Lan Q Liu PY Haase J Bell JL Huttelmaier S Liu T. The critical role of RNA m(6) a methylation in Cancer. Cancer Res. 2019;79(7):1285\u201392.","DOI":"10.1158\/0008-5472.CAN-18-2965"},{"key":"e_1_3_2_1_20_1","doi-asserted-by":"crossref","unstructured":"Sun T Wu R Ming L. The role of m6A RNA methylation in cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019;112:108613.  Sun T Wu R Ming L. The role of m6A RNA methylation in cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019;112:108613.","DOI":"10.1016\/j.biopha.2019.108613"},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.045"},{"key":"e_1_3_2_1_22_1","article-title":"RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma","volume":"1","author":"Shen Shen","year":"2021","unstructured":"Shen Shen , Jingya Yan , Yize Zhang , Zihui Dong , Jiyuan Xing , Yuting He. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma . Annals of Translational Medicine.9 . 1 ( 2021 ):59 Shen Shen, Jingya Yan, Yize Zhang, Zihui Dong, Jiyuan Xing, Yuting He. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma. Annals of Translational Medicine.9.1(2021):59","journal-title":"Annals of Translational Medicine.9"},{"key":"e_1_3_2_1_23_1","doi-asserted-by":"crossref","unstructured":"Strobel O. Neoptolemos J. J\u00e4ger D. & B\u00fcchler M. W. Optimizing the outcomes of pancreatic cancer surgery. Nat. Rev. Clin. Oncol. 2019;16 11\u201326.  Strobel O. Neoptolemos J. J\u00e4ger D. & B\u00fcchler M. W. Optimizing the outcomes of pancreatic cancer surgery. Nat. Rev. Clin. Oncol. 2019;16 11\u201326.","DOI":"10.1038\/s41571-018-0112-1"},{"key":"e_1_3_2_1_24_1","doi-asserted-by":"crossref","unstructured":"Huang H Weng H Chen J. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell (2020) 37: 270\u201388.  Huang H Weng H Chen J. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell (2020) 37:270\u201388.","DOI":"10.1016\/j.ccell.2020.02.004"},{"key":"e_1_3_2_1_25_1","doi-asserted-by":"crossref","unstructured":"Wang T Kong S Tao M Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer (2020) 19: 88\u2013105.  Wang T Kong S Tao M Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer (2020) 19:88\u2013105.","DOI":"10.1186\/s12943-020-01204-7"},{"key":"e_1_3_2_1_26_1","doi-asserted-by":"crossref","unstructured":"Chen XY Zhang J Zhu JS. The role of m6A RNA methylation in human cancer. Mol Cancer (2019) 18: 103\u201311.  Chen XY Zhang J Zhu JS. The role of m6A RNA methylation in human cancer. Mol Cancer (2019) 18:103\u201311.","DOI":"10.1186\/s12943-019-1033-z"},{"key":"e_1_3_2_1_27_1","first-page":"621","article-title":"promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo K.","year":"2018","unstructured":"K. Taketo , M. Konno , A. Asai , J. Koseki , M. Toratani , T. Satoh , Y. Doki , M. Mori , H. Ishii , K. Ogawa . The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells . Int. J. Oncol. , 52 ( 2018 ), pp. 621 - 629 K. Taketo, M. Konno, A. Asai, J. Koseki, M. Toratani, T. Satoh, Y. Doki, M. Mori, H. Ishii, K. Ogawa. The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells. Int. J. Oncol., 52 (2018), pp. 621-629","journal-title":"Int. J. Oncol."},{"key":"e_1_3_2_1_28_1","doi-asserted-by":"crossref","unstructured":"Ma S Chen C Ji X Liu J Zhou Q Wang G The Interplay Between M6a RNA Methylation and Noncoding RNA in Cancer. J Hematol Oncol (2019) 12:121.  Ma S Chen C Ji X Liu J Zhou Q Wang G The Interplay Between M6a RNA Methylation and Noncoding RNA in Cancer. J Hematol Oncol (2019) 12:121.","DOI":"10.1186\/s13045-019-0805-7"},{"key":"e_1_3_2_1_29_1","doi-asserted-by":"crossref","unstructured":"Zhong Xiaoxiao Li Jun Wu Xin etal Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer. Frontiers in Oncology. (2021)11: 4195.  Zhong Xiaoxiao Li Jun Wu Xin et al. Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer. Frontiers in Oncology. (2021)11:4195.","DOI":"10.3389\/fonc.2021.742944"},{"key":"e_1_3_2_1_30_1","doi-asserted-by":"crossref","unstructured":"Huang Wei Li Gen Wang Zihang Zhou Lin A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma. Frontiers in Oncology. (2021)10: 3313  Huang Wei Li Gen Wang Zihang Zhou Lin A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma. Frontiers in Oncology. (2021)10:3313","DOI":"10.3389\/fonc.2020.567931"},{"key":"e_1_3_2_1_31_1","first-page":"1168","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"10","author":"Marayati Richard","unstructured":"Moffitt, Richard A.; Marayati , Raoud; Flate, Elizabeth L . Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma . NATURE GENETICS , 10 , 47(2015): 1168 - 1178 Moffitt, Richard A.; Marayati, Raoud; Flate, Elizabeth L. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. NATURE GENETICS ,10, 47(2015): 1168-1178","journal-title":"NATURE GENETICS"},{"issue":"8","key":"e_1_3_2_1_32_1","first-page":"2077","article-title":"Comprehensive Analysis of LincRNAs","volume":"12","author":"Markus Gla","year":"2020","unstructured":"Markus Gla , Agnes Dorn , Stefan H\u00fcttelmaier and Monika Haemmerle and Tony Gutschner . Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. Cancers , 2020 , 12 ( 8 ): 2077 . Markus Gla , Agnes Dorn, Stefan H\u00fcttelmaier and Monika Haemmerle and Tony Gutschner. Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer. Cancers, 2020, 12(8):2077.","journal-title":"Classical and Basal-Like Subtypes of Pancreatic Cancer. Cancers"},{"key":"e_1_3_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S226801"},{"key":"e_1_3_2_1_34_1","first-page":"13487","article-title":"promotes cancer cell proliferation in bladder cancer through miRNA-150","volume":"8","author":"Xu HR","unstructured":"Luo, HR , Xu , CD , Le , W, Ge, BJ , Wang , TR. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150 . JOURNAL OF CELLULAR BIOCHEMISTRY. 8 ,120(2019): 13487 - 13493 Luo, HR, Xu, CD, Le, W, Ge, BJ, Wang, TR. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. JOURNAL OF CELLULAR BIOCHEMISTRY. 8,120(2019): 13487-13493","journal-title":"JOURNAL OF CELLULAR BIOCHEMISTRY."},{"key":"e_1_3_2_1_35_1","doi-asserted-by":"crossref","unstructured":"Song H Liu Y Li XQ Chen SH Xie RZ Chen DB Gao HW Wang GQ Cai B Yang XY. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation. CLINICAL AND TRANSLATIONAL MEDICINE. 10 7(2020)  Song H Liu Y Li XQ Chen SH Xie RZ Chen DB Gao HW Wang GQ Cai B Yang XY. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation. CLINICAL AND TRANSLATIONAL MEDICINE. 10 7(2020)","DOI":"10.1002\/ctm2.220"},{"key":"e_1_3_2_1_36_1","first-page":"795","volume":"10","author":"Wang XY","unstructured":"Wang XY , Han LN , Shan SM, Sun YX , Mao YM . INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 10 , 1(2017): 795 - 803 Wang XY ,Han LN, Shan SM, Sun YX ,Mao YM. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY. 10, 1(2017): 795-803","journal-title":"INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY."},{"volume-title":"AACR Annual Meeting ,2018; Chicago, IL","author":"Kit-Nam Chin Isabella","key":"e_1_3_2_1_37_1","unstructured":"Isabella Kit-Nam Chin , Goretti Hoi-Yan Cheung , Hazel Yuk-Yan Kwok , Victor Wan-San Ma , Eunice Yuen-Ting Lau and William Chi-Shing Cho . The novel function of keratin 14 (KRT14) in regulating cancer stem cell properties in lung adenocarcinoma . AACR Annual Meeting ,2018; Chicago, IL Isabella Kit-Nam Chin, Goretti Hoi-Yan Cheung, Hazel Yuk-Yan Kwok, Victor Wan-San Ma, Eunice Yuen-Ting Lau and William Chi-Shing Cho. The novel function of keratin 14 (KRT14) in regulating cancer stem cell properties in lung adenocarcinoma. AACR Annual Meeting ,2018; Chicago, IL"},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"crossref","unstructured":"Liu Weidong Xu Zhentao Zhou Jie High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data. Frontiers in Oncology (2020)10: 627  Liu Weidong Xu Zhentao Zhou Jie High Levels of HIST1H2BK in Low-Grade Glioma Predicts Poor Prognosis: A Study Using CGGA and TCGA Data. Frontiers in Oncology (2020)10:627","DOI":"10.3389\/fonc.2020.00627"}],"event":{"name":"ACAI'21: 2021 4th International Conference on Algorithms, Computing and Artificial Intelligence","acronym":"ACAI'21","location":"Sanya China"},"container-title":["2021 4th International Conference on Algorithms, Computing and Artificial Intelligence"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3508546.3508584","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3508546.3508584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T19:30:41Z","timestamp":1750188641000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3508546.3508584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":38,"alternative-id":["10.1145\/3508546.3508584","10.1145\/3508546"],"URL":"https:\/\/doi.org\/10.1145\/3508546.3508584","relation":{},"subject":[],"published":{"date-parts":[[2021,12,22]]},"assertion":[{"value":"2022-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}